InMed Pharmaceuticals, Inc.(NASDAQ : INM)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
Health Technology » Pharmaceuticals Other
|SAVA||Cassava Sciences, Inc.||-32.72%||69.53||0.0%||$388.91m|
|VRX||Valeant Pharmaceuticals International, Inc.||-1.18%||29.24||14.1%||$172.05m|
|HZNP||Horizon Therapeutics Plc||-2.52%||100.02||5.5%||$112.77m|
|JAZZ||Jazz Pharmaceuticals Plc||-0.63%||169.52||2.2%||$84.19m|
|PRGO||Perrigo Co. Plc||0.44%||48.10||6.9%||$48.96m|
|ENDP||Endo International Plc||1.20%||5.06||8.6%||$46.03m|
|BHC||Bausch Health Cos., Inc.||-1.18%||29.24||0.0%||$42.50m|
|UTHR||United Therapeutics Corp.||-1.24%||181.93||14.0%||$39.35m|
|SAGE||SAGE Therapeutics, Inc.||-0.91%||43.73||7.6%||$32.31m|
|NTEC||Intec Pharma Ltd.||-16.68%||11.29||0.0%||$31.56m|
|IRWD||Ironwood Pharmaceuticals, Inc.||0.84%||13.27||9.6%||$25.32m|
|PLXP||PLx Pharma, Inc.||0.21%||18.73||0.1%||$17.71m|
InMed Pharmaceuticals, Inc. engages in the research and development of cannabinoid-based therapies and biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids. It offers pipeline of medications that target diseases with unmet medical needs, such as epidermolysis bullosa, glaucoma, and orofacial pain. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.